Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) New York MDRU |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00015275 |
The purpose of this study is to define pathophysiological subtypes of abnormalities in subjects with cocaine dependence.
Condition | Intervention | Phase |
---|---|---|
Cocaine-Related Disorders Substance-Related Disorders |
Behavioral: Cocaine-Related Disorders |
Phase IV |
Study Type: | Interventional |
Study Design: | Diagnostic, Open Label |
Official Title: | Pathophysiological Subtyping of Abnormalities in Cocaine Dependence |
Estimated Enrollment: | 0 |
The objective of this study is to define subgroups of patients with differential treatment outcome on the basis of differential baseline electrophysiological clusters.
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Cocaine dependence. Seeking residential treatment.
Study ID Numbers: | NIDA-5-0013-9, Y01-5-0013-9 |
Study First Received: | April 18, 2001 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00015275 History of Changes |
Health Authority: | United States: Federal Government |
Cocaine-Related Disorders Dopamine Uptake Inhibitors Neurotransmitter Agents Central Nervous System Depressants Disorders of Environmental Origin Anesthetics Cardiovascular Agents Anesthetics, Local |
Dopamine Mental Disorders Substance-Related Disorders Vasoconstrictor Agents Dopamine Agents Peripheral Nervous System Agents Congenital Abnormalities Cocaine |
Cocaine-Related Disorders Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Disease Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Central Nervous System Depressants Anesthetics Disorders of Environmental Origin Cardiovascular Agents Anesthetics, Local |
Pharmacologic Actions Pathologic Processes Sensory System Agents Mental Disorders Therapeutic Uses Substance-Related Disorders Vasoconstrictor Agents Dopamine Agents Peripheral Nervous System Agents Cocaine Central Nervous System Agents |